Besancon M, Shin J M, Mercier F, Munson K, Miller M, Hersey S, Sachs G
Department of Physiology, University of California, Los Angeles.
Biochemistry. 1993 Mar 9;32(9):2345-55. doi: 10.1021/bi00060a028.
The gastric H+,K(+)-ATPase is an alpha beta heterodimer with close homology to the Na+,K(+)-ATPase. Digestion of intact cytoplasmic-side-out vesicles at a trypsin to protein ratio of 1/4 removed most of the cytoplasmic protein, leaving membrane-spanning pairs in high yield. These were visualized on gels and poly(vinylidene difluoride) (PVDF) membranes by sodium dodecyl sulfate solubilization of the membrane-embedded segments and labeling of the cysteine residues with fluorescein maleimide prior to electrophoresis. The membrane-spanning residues of the alpha subunit were found between positions 104 and 162 (M1/M2), 291 and 358(M3/M4), 776 and 835 (M5/M6), and 853 and 946 (M7/M8). Although this method did not detect membrane retention of the hydrophobic sequences subsequent to position 946, it provided biochemical evidence for at least eight membrane segments in the catalytic subunit. Intact vesicles containing this enzyme transport acid in the presence of KCl, valinomycin, and MgATP. Omeprazole accumulates in these acidified vesicles and converts to a cationic sulfenamide. This forms disulfides with accessible cysteines. The reaction with this extracytoplasmic thiol reagent inhibits ATPase activity. Full inhibition was obtained with a stoichiometry of 2.2 mol of omeprazole bound/mg of protein. Only the alpha subunit was labeled. The cysteines reacting with omeprazole were defined by proteolytic cleavage of 3H- or 14C-omeprazole-labeled enzyme followed by peptide sequencing of fragments separated on tricine gradient gels and transferred to PVDF membranes. Tryptic digestion at a 1/40 trypsin to protein ratio in the presence of ligands that stabilize the E2P form of the enzyme produced two large fragments, one of 68 kDa stretching from Glu47 to probably Arg666 that contained minor labeling and the other of 333 kDa beginning at Ala671 and extending to probably Arg946 that contained greater than 85% of the label. Digestion of labeled vesicles at 1/75 or 1/4 trypsin to protein ratios gave radioactive patterns consistent with labeling at Cys813 and/or Cys822 and at Cys892 and/or Cys927 and/or Cys938. V8 protease digestion of the solubilized alpha subunit produced a fragment extending from Ser838 to possible Asp900 that was omeprazole-labeled, showing that Cys892 was labeled and Cys927 and Cys938 were not. Hence, omeprazole labels the H+,K(+)-ATPase at cysteines within the M5/M6 and M7/M8 regions of the alpha subunit, accounting for its inhibitory action in vivo and in vitro.
胃H⁺,K⁺-ATP酶是一种αβ异二聚体,与Na⁺,K⁺-ATP酶有高度同源性。以胰蛋白酶与蛋白质1/4的比例消化完整的胞质面向外的囊泡,去除了大部分胞质蛋白,以高产率留下跨膜二聚体。通过十二烷基硫酸钠溶解膜嵌入片段,并在电泳前用荧光素马来酰亚胺标记半胱氨酸残基,这些二聚体在凝胶和聚偏二氟乙烯(PVDF)膜上得以可视化。发现α亚基的跨膜残基位于104至162位(M1/M2)、291至358位(M3/M4)、776至835位(M5/M6)和853至946位(M7/M8)。尽管该方法未检测到946位之后疏水序列的膜保留情况,但它为催化亚基中至少八个膜片段提供了生化证据。含有这种酶的完整囊泡在氯化钾、缬氨霉素和MgATP存在下运输酸。奥美拉唑在这些酸化囊泡中积累并转化为阳离子亚磺酰胺。这与可及的半胱氨酸形成二硫键。与这种胞外硫醇试剂的反应抑制ATP酶活性。以2.2摩尔奥美拉唑结合/毫克蛋白质的化学计量比可实现完全抑制。仅α亚基被标记。通过对3H或14C-奥美拉唑标记的酶进行蛋白水解切割,然后对在tricine梯度凝胶上分离并转移到PVDF膜上的片段进行肽测序,确定了与奥美拉唑反应的半胱氨酸。在稳定酶的E2P形式的配体存在下,以胰蛋白酶与蛋白质1/40的比例进行胰蛋白酶消化产生两个大片段,一个68 kDa,从Glu47延伸至可能的Arg666,含有少量标记,另一个33 kDa,从Ala671开始延伸至可能的Arg946,含有超过85%的标记。以1/75或1/4胰蛋白酶与蛋白质的比例消化标记的囊泡,得到的放射性模式与在Cys813和/或Cys822以及Cys892和/或Cys927和/或Cys938处的标记一致。对溶解的α亚基进行V8蛋白酶消化产生一个从Ser838延伸至可能的Asp900的片段,该片段被奥美拉唑标记,表明Cys892被标记而Cys927和Cys938未被标记。因此,奥美拉唑在α亚基的M5/M6和M7/M8区域内的半胱氨酸处标记H⁺,K⁺-ATP酶,这解释了其在体内和体外的抑制作用。